The Tanzania Diabetes Devices Market is expected to witness growth from $9 Mn in 2022 to $17 Mn in 2030 with a CAGR of 8.10 % for the forecasted year 2022-2030. Tanzania's healthcare infrastructure has recently undergone improvements, including the development of medical facilities and the accessibility of qualified medical professionals. This improves diabetes patients’ access to diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
The Tanzania Diabetes Devices Market is at around $9 Mn in 2022 and is projected to reach $17 Mn in 2030, exhibiting a CAGR of 8.10% during the forecast period. In Tanzania, the average person's healthcare expenses were $41 in 2021. The United Republic of Tanzania saw a rise in health spending per person from $20 in 2015 to $40 in 2019, growing at an average annual rate of 6.91%. Tanzania's health industry receives $0.94 billion in nominal funding in 2020, which is a 0.4% decrease from the $0.93 billion allocated in 2018. From 7.0% and 1.80%, respectively, the allotment has dropped to 6.7% of the total national budget and 1.5% of GDP.
The number of diabetics in Tanzania increased by 4.6%, or about 1.3 million persons, between 2010 to 2021. 29,900 brand-new cases of diabetes were reported in Tanzania in 2021. In order to properly manage diabetes, people must be able to monitor their blood glucose levels at home using diabetes devices. They are portable, simple to use, and quick to produce outcomes. Insulin shots for diabetes patients who need to use insulin pens are more convenient. They make it simpler for people to control their diabetes while they are on the go because they are portable, discrete, and simple to use. Insulin is constantly delivered throughout the day by tiny devices called insulin pumps. They can aid diabetics in better controlling their blood sugar levels and lowering their risk of developing problems.
Market Growth Drivers
Tanzania's healthcare infrastructure has recently undergone improvements, including the development of medical facilities and the accessibility of qualified medical professionals. This improves diabetes patients’ access to diabetes devices and other diabetes management aids. Demand for these products in Tanzania is being driven by the creation of new and improved diabetes devices. Diabetes devices are becoming easier to use, more accurate, and more user-friendly thanks to technological developments. The prevalence of diabetes is increasing in Tanzania, which is driving demand for diabetes devices such as blood glucose meters, insulin pens, and insulin pumps.
Market Restraints
In Tanzania, there is an increase in diabetes awareness, but more instruction and awareness-raising efforts are still required to help people comprehend the significance of managing diabetes and the role that diabetes devices play in this process. This may lower the demand for diabetes devices and make it more challenging for producers to find new clients.
Key Players
Diabetes device regulation in Tanzania is handled by the Medical Devices Regulatory Authority (MDRA). The MDRA is in charge of making sure diabetes gadgets are secure, efficient, and of high calibre. The body is also in charge of registering diabetes devices and keeping an eye on their use across the nation. Diabetes gadgets can only be imported and exported to Tanzania under certain conditions. Before being brought into the nation, all diabetes devices must be registered with the MDRA. Before importing diabetes devices, importers must also acquire licences from the Tanzania Food and Drugs Authority (TFDA). Setting and enforcing high standards for diabetes devices in Tanzania is the responsibility of the Tanzania Bureau of Standards (TBS). Before being sold in the nation, all medical devices, including those used to treat diabetes, must meet TBS requirements.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents
By End User (Revenue, USD Billion):
The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.